Thomas Mullen

Company: SeQure Dx

Job title: Chief Scientific Officer

Seminars:

One Genome or Thousands of Genomes? The importance of evaluating population variants 1:40 pm

What does the FDA gene-editing draft guidance ask for? Why are population variants important for off-target risk assessments? Methods to efficiently generate and match risk assessments with the intent to treat populationRead more

day: Day One